World Congress on Treatment and Research in Multiple Sclerosis
 Subscribe to our Newsletter
World Congress on Treatment and Research in Multiple Sclerosis
 About Montréal
Destination
General Information
 About Conference
Who We Are
Montreal Convention Center (Palais des congrès
Official Carrier
Important Information
 Contact Us
 Printed Material
 Home
World Congress on Treatment and Research in Multiple Sclerosis
 Acknowledgement

Commitees
Programs
Program Overview
Scientific Program
Teaching Courses
Poster Sessions
Satellite Symposia
Social Events
Registration
Exhibitors and Sponsors
Acknowledgements
Instruction for Presenter
Call for Abstracts
CME Credits
Add on Meeting
Housing
Housing Map
Tours
Medias/Press Info

Satellite symposia

These programs are not part of the official World Congress on Treatment and Research in Multiple Sclerosis. The Congress Organizers do not endorse products, services or manufacturers. Such names appear in congress materials and sessions solely because they are considered valuable information. The Congress Organizers assume no liability for the use or contents of any product or service mentioned. Trademarks used in Congress materials and sessions are the property of their respective owners.

WEDNESDAY, SEPTEMBER 17

12.30-14.00 Room 517D

Satellite Symposium – European Charcot Foundation

Methylation and Remyelination: Epigenetic Activation of Remyelination in Adult Brain

14.30-15.30 Room 517A

Sponsored Satellite Symposium - sanofi-aventis

Teriflunomide: Progress in the Development of an Oral Medication for Multiple Sclerosis www.onlinemeetinginfo.org

16.00-17.00 Room 520

Sponsored Satellite Symposium - MS Forum

Issues in MS Diagnosis

17.30-18.30 Room 517A

Sponsored Satellite Symposium - Bayer HealthCare

Contemporary Approaches to MS Management

THURSDAY, SEPTEMBER 18

12.45-13.45 Room 517A

Sponsored Satellite Symposium - Teva & sanofi-aventis

Improving the Course of MS: Treat Today for a Better Tomorrow

18.00-19.00 Room 517A

Sponsored Satellite Symposium - EMD Serono

Improving MS Treatment: Building on the Past to Prepare for the Future

19.15-20.15 Room 517D

Sponsored Satellite Symposium - Biogen Idec and Elan

Taking on MS – Targeting Defined Pathways

FRIDAY, SEPTEMBER 19

07.45-08.45 Room 517

Sponsored Satellite Symposium – Novartis

Oral Fingolimod: From Innovative Science to Clinical Promise

www.novartissatellitesymposium.com/Invitation.pdf

12.45-13.45 Room 517A

Sponsored Satellite Symposium - Bayer HealthCare and Genzyme

Researching the Potential for a New Treatment Paradigm: Alemtuzumab in MS

18.00-19.00 Room 517D

Sponsored Satellite Symposium - Biogen Idec and Elan

Discovering New Pathways in MS

19.15-20.15 Room 517A

Sponsored Satellite Symposium - EMD Serono

Oral Therapy: Increasing Treatment Options in MS

COMMERCIAL SUPPORT

Platinum





Gold




Silver


Bronze


ORGANIZATIONAL
SUPPORT




 

 
About Montréal About the Conference Contact UsPrinted MaterialHome